Zylox-Tonbridge Medical Technology Co., Ltd. (HKEX: 2190, "Zylox-Tonbridge" or the "Company") today announced its annual ...
Five major physician practice deals in 2026 reveal an industry at an inflection point. Independent practices are becoming harder to sustain, academic partnerships are fracturing, and a new mix of ...
A deep dive into the iconic late-night block that shaped the tastes of a bleary-eyed, post-ironic generation of comedy fans.
The noninferiority trial of patients at risk for both bleeding and stroke, in a surprise turn, found standard care to be superior.
JenaValve's Trilogy System, FDA-approved for severe AR, offers secure anchoring without calcium. It is a breakthrough for high-risk U.S. patients.
JenaValve has secured the FDA’s approval for its minimally invasive heart implant, making it the first to claim a U.S. green light to treat severe backflow through the aortic valve. | JenaValve has ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results